An innovative cancer-vaccine & service company

Linking preclinical data to clinical reality™

Immuneed AB is a biotech company focusing on therapeutic vaccine development for cancer treatment. Immuneed also offers a specialized service for advanced characterization and detection of acute immune-related side effects of biopharmaceuticals in human whole-blood.

Our vision is to provide breakthrough immunotherapeutics to areas with high unmet needs and where an immune-mediated anti-tumor response can play a difference. We will also be world leading in immunological evaluation of biopharmaceuticals in human whole blood, with a specific focus on monoclonal antibodies. Linking preclinical data to clinical reality™

Our peptide vaccine platform

We are developing a new generation therapeutic peptide-based vaccine building on a unique, patent pending idea that will enhance both peptide uptake and cellular immune activation. The primary focus early stage high risk prostate cancer but the platform can be used for developing vaccines for other indications.

Advanced characterization services for biologicals

The specialized service we offer is based on a unique human whole-blood loop assay, for detection of acute immune-related side effects of biopharmaceuticals (cytokine release), which provides a better understanding of first-in-man reactions prior to clinical trial entry. The assay platform can also be used to perform mode-of-action studies.

Pipeline

Our services